Is Hypnosis Just a Placebo? What the Science Says

“It’s just a placebo.” It’s the most common dismissal hypnosis gets — and it’s half right, which is exactly why it misleads.

Here’s the honest reconciliation. Hypnosis shares machinery with the placebo response: both run on suggestion, expectancy, and top-down control of perception. But hypnosis is not reducible to placebo. When researchers use hypnotic suggestion to turn pain down, the change shows up as measurable, specific shifts in brain activity — and those shifts don’t match the placebo signature. The overlap is real. So is the dissociation. Below is what the imaging actually shows, and where the “just a placebo” line breaks.

Do hypnosis and placebo run on the same machinery?

Partly, yes — and pretending otherwise oversells hypnosis. Both are forms of top-down regulation: the brain modifying perception based on expectation, attention, and belief rather than the raw signal coming in.

A 2012 literature review in the Journal of European Psychology Students (Kirjanen) compared functional-imaging studies of hypnotic and placebo analgesia head to head. The shared ground is substantial. In both, reduced pain ratings track changes across the “pain network” — the anterior cingulate cortex (ACC), insula, thalamus, and prefrontal cortex. In both, the prefrontal cortex ramps up in a way that correlates with how much relief a person expects. That prefrontal-expectancy link is the fingerprint of a belief-driven effect, and hypnosis wears it too.

So the skeptic isn’t hallucinating. Expectancy is in the mix. The question is whether that’s all that’s in the mix.

If they overlap, what makes hypnosis different in the brain?

The same review found the machinery diverges once you look past the shared pain network. During hypnotic pain relief, activity changes appear in the occipital (visual) cortex and basal ganglia — regions tied to imagery and movement regulation — a pattern that doesn’t show up in placebo studies. Placebo analgesia, meanwhile, recruits its own distinct set: the amygdala, hypothalamus, hippocampus, periaqueductal grey, and nucleus accumbens — limbic and reward-and-opioid structures largely absent from the hypnosis findings. The review’s blunt conclusion: hypnosis is “not equal to common placebo in terms of brain activity.”

There’s a neurochemical tell, too. The placebo response is at least partly opioid-mediated — block it with the opioid antagonist naloxone and it often weakens. Hypnotic analgesia, in the studies to date, is not reversed by naloxone. Different chemistry, not just a different label.

The single cleanest demonstration predates the comparison. In a landmark 1997 Science study, Rainville and colleagues used hypnotic suggestion to alter only the unpleasantness of a painful stimulus — how much it bothered people — while leaving the raw intensity untouched. PET imaging showed significant changes in pain-evoked activity in the anterior cingulate cortex, while the primary somatosensory cortex stayed unchanged. Suggestion surgically edited the affective dimension of pain and left the sensory dimension alone. That’s not a vague feel-good effect. That’s a targeted change in a specific circuit.

Does hypnosis leave its own signature — even without pain?

Yes — and this is where the “just relaxation” version also falls apart. A 2016 Stanford fMRI study (Jiang et al., Cerebral Cortex) screened 545 people and scanned 57 selected for very high or very low hypnotizability. During hypnosis, the highly hypnotizable showed three consistent changes: reduced activity in the dorsal anterior cingulate cortex, increased connectivity between the dorsolateral prefrontal cortex and the insula, and reduced connectivity between the executive-control network and the default-mode network.

Read plainly: the brain’s salience monitor quiets, executive control couples to body-state awareness, and self-referential “mind-wandering” chatter decouples. That maps onto what hypnosis feels like — absorbed focus, less self-consciousness, more somatic control — and it’s a state signature, not a placebo pill’s afterglow.

So does hypnosis behave differently from placebo?

The behavioral dissociation is the tiebreaker. If hypnosis were merely placebo, the two should rise and fall together across people. They don’t.

A review in the American Journal of Psychotherapy (Van Dyck & Hoogduin, 1990) laid out the split: placebo effects are not related to hypnotizability, yet the clinical results of hypnosis are related to hypnotizability — for conditions like pain and anxiety. Two effects that scaled with the same underlying trait would be one effect. These scale differently, so they aren’t. (Consistent with this, earlier experimental work found highly hypnotizable people report less pain under hypnosis than under placebo.)

That trait — responsiveness — is real and measurable, and it’s the crux of why hypnosis isn’t one-size-fits-all: see who actually responds to hypnosis and why. And the “it’s just sleep” objection fails for the same reason the placebo one does — the brainwaves say otherwise.

The takeaway

“Just a placebo” is a category error dressed as a dismissal. Hypnosis genuinely shares the placebo response’s engine — suggestion and expectancy, run through the prefrontal cortex. But it also produces effects placebo doesn’t: a distinct imaging signature, analgesia that shrugs off an opioid blocker, and outcomes that track hypnotizability where placebo doesn’t. The intellectually honest position isn’t “it’s real magic” or “it’s fake” — it’s that hypnosis is a specific, trainable brain state that overlaps with placebo without collapsing into it. For the full mechanism, see what actually happens in your brain during hypnosis and the broader science of clinical hypnosis.